CARL WINKLER: Open Payments
NPI 1497433270 · VALATIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 20 payments from 6 companies in 2025. Trend: 2023 $237 · 2024 $229 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $257 |
| Novo Nordisk Inc | 4 | $90 |
| Exact Sciences Corporation | 2 | $50 |
| Lilly USA, LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: FARXIGA, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, TRELEGY ELLIPTA, CONTRAVE, BREZTRI.
Industry payments across NY — which companies pay providers there.
